Innovators for Animals: Andrea Gonzales
Hear how our leader of Global Therapeutics for Companion Animals came to Zoetis and why itchy dogs are personal for this scientist.
Andrea Gonzales, the Vice President of Global Companion Animal Therapeutics at Zoetis, expresses her passion for uncovering new scientific insights that lead to innovative solutions for pets and their owners. She takes pride in her involvement with the dermatology teams that developed Apoquel® and Cytopoint®, therapies that effectively address allergic skin disease in dogs. Andrea's personal experience with her dogs suffering from skin allergies motivated her to find a solution to improve pets’ quality of life. For the future, she looks forward to continuing research to understand allergic skin disease in other species.
CYTOPOINT INDICATION: Cytopoint has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.
APOQUEL INDICATION: Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
APOQUEL IMPORTANT SAFETY INFORMATION: Do not use Apoquel in dogs less than 12 months of age or those with serious infections. Apoquel may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. New neoplastic conditions (benign and malignant) were observed in clinical studies and post-approval. Apoquel has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. Apoquel has been used safely with many common medications including parasiticides, antibiotics and vaccines. See the full Prescribing Information.
